Medifast Inc $MED Stock Position Decreased by Lido Advisors LLC

Lido Advisors LLC lowered its holdings in Medifast Inc (NYSE:MED) by 44.7% during the first quarter, HoldingsChannel.com reports. The fund owned 183,035 shares of the specialty retailer’s stock after selling 147,668 shares during the period. Lido Advisors LLC’s holdings in Medifast were worth $1,865,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently made changes to their positions in MED. Steamboat Capital Partners LLC acquired a new stake in shares of Medifast during the 4th quarter worth approximately $2,952,000. Charles Schwab Investment Management Inc. grew its stake in Medifast by 30.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 776,829 shares of the specialty retailer’s stock worth $8,297,000 after buying an additional 181,618 shares during the last quarter. Bank of America Corp DE grew its stake in Medifast by 37.4% during the 2nd quarter. Bank of America Corp DE now owns 396,369 shares of the specialty retailer’s stock worth $5,569,000 after buying an additional 107,854 shares during the last quarter. Victory Capital Management Inc. acquired a new stake in Medifast in the third quarter worth $867,000. Finally, Bridgeway Capital Management LLC increased its position in Medifast by 104.5% in the third quarter. Bridgeway Capital Management LLC now owns 118,477 shares of the specialty retailer’s stock worth $1,620,000 after buying an additional 60,533 shares during the period. 95.51% of the stock is owned by institutional investors.

Insider Buying and Selling at Medifast

In other news, Director Scott Schlackman bought 2,500 shares of the company’s stock in a transaction dated Monday, May 11th. The shares were acquired at an average cost of $12.53 per share, with a total value of $31,325.00. Following the completion of the transaction, the director directly owned 30,549 shares in the company, valued at approximately $382,778.97. The trade was a 8.91% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 3.70% of the stock is owned by company insiders.

Medifast Stock Performance

Shares of MED stock opened at $9.65 on Monday. Medifast Inc has a 1 year low of $9.22 and a 1 year high of $15.20. The stock has a fifty day moving average of $11.38 and a two-hundred day moving average of $11.10. The firm has a market capitalization of $107.30 million, a PE ratio of -5.27 and a beta of 0.65.

Medifast (NYSE:MED) last released its earnings results on Monday, May 4th. The specialty retailer reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.55) by $0.36. Medifast had a negative net margin of 5.78% and a negative return on equity of 4.80%. The firm had revenue of $76.04 million for the quarter, compared to analysts’ expectations of $69.20 million. Medifast has set its FY 2026 guidance at -2.750–1.550 EPS and its Q2 2026 guidance at -1.000–0.500 EPS. Equities research analysts predict that Medifast Inc will post -1.97 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on MED shares. Weiss Ratings downgraded shares of Medifast from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 6th. Zacks Research upgraded shares of Medifast from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Medifast currently has an average rating of “Hold” and a consensus target price of $12.00.

Medifast Profile

Medifast, Inc (NYSE: MED) is a health and wellness company specializing in clinically supported weight-loss, weight-management and healthy living products and services. Through its OPTAVIA brand, the company offers a range of meal replacement products, snacks, supplements and coaching programs designed to support metabolic health and sustainable lifestyle changes. Medifast markets its products directly to consumers via a network of independent distributors—known as OPTAVIA Coaches—who provide personalized guidance and support throughout the client’s weight‐loss journey.

Founded in 1980 by William Vitale and headquartered in Baltimore, Maryland, Medifast has grown into a nationally recognized provider of nutrition and weight‐management solutions.